NCT00009048View on ClinicalTrials.gov

EMD 128130 for the Treatment of Parkinson's Disease

PHASE2CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

January 31, 2001

Study Completion Date

December 31, 2003

Conditions
Parkinson's Disease
Interventions
DRUG

EMD 128130

DRUG

IV Levodopa

Trial Locations (1)

20892

National Institute of Neurological Disorders and Stroke (NINDS), Bethesda

All Listed Sponsors
lead

National Institute of Neurological Disorders and Stroke (NINDS)

NIH

NCT00009048 - EMD 128130 for the Treatment of Parkinson's Disease | Biotech Hunter | Biotech Hunter